• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New, long-term insights from the Adenoma Prevention with Celecoxib Trial on a promising but troubled class of drugs.

作者信息

Dubois Raymond N

机构信息

Department of Cancer Biology and Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Cancer Prev Res (Phila). 2009 Apr;2(4):285-7. doi: 10.1158/1940-6207.CAPR-09-0038. Epub 2009 Mar 31.

DOI:10.1158/1940-6207.CAPR-09-0038
PMID:19336723
Abstract
摘要

相似文献

1
New, long-term insights from the Adenoma Prevention with Celecoxib Trial on a promising but troubled class of drugs.塞来昔布预防腺瘤试验对一类有前景但存在问题的药物的新的长期见解。
Cancer Prev Res (Phila). 2009 Apr;2(4):285-7. doi: 10.1158/1940-6207.CAPR-09-0038. Epub 2009 Mar 31.
2
Does celecoxib use increase the risk of cardiovascular events?使用塞来昔布会增加心血管事件的风险吗？
Gastroenterology. 2005 Oct;129(4):1348-50. doi: 10.1053/j.gastro.2005.08.029.
3
Letter by Cen regarding article, "Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas".岑就《塞来昔布在两项预防结直肠癌腺瘤试验中对心血管事件和血压的影响》一文所写的信函。
Circulation. 2007 Mar 27;115(12):e348; author reply e349. doi: 10.1161/CIRCULATIONAHA.106.672097.
4
Celecoxib and CVS risk--lessons from the APC and PreSAP studies.
Rheumatology (Oxford). 2007 Apr;46(4):561-2. doi: 10.1093/rheumatology/kel398. Epub 2006 Nov 28.
5
Risks and benefits of celecoxib to prevent recurrent adenomas.塞来昔布预防复发性腺瘤的风险与获益
N Engl J Med. 2006 Aug 31;355(9):950-2. doi: 10.1056/NEJMe068158.
6
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.在一项预防结直肠腺瘤的临床试验中与塞来昔布相关的心血管风险。
N Engl J Med. 2005 Mar 17;352(11):1071-80. doi: 10.1056/NEJMoa050405. Epub 2005 Feb 15.
7
Arthritis medicines and cardiovascular events--"house of coxibs".关节炎药物与心血管事件——“昔布类药物家族”
JAMA. 2005 Jan 19;293(3):366-8. doi: 10.1001/jama.293.3.366. Epub 2004 Dec 28.
8
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas.塞来昔布在两项预防结直肠腺瘤试验中对心血管事件和血压的影响。
Circulation. 2006 Sep 5;114(10):1028-35. doi: 10.1161/CIRCULATIONAHA.106.636746.
9
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.COX-2选择性非甾体抗炎药与心血管疾病
Pharmacoepidemiol Drug Saf. 2003 Jan-Feb;12(1):67-70. doi: 10.1002/pds.798.
10
Risks and benefits of celecoxib to prevent colorectal adenomas.塞来昔布预防结直肠腺瘤的风险与益处。
N Engl J Med. 2006 Nov 30;355(22):2371; author reply 2371-3. doi: 10.1056/NEJMc062700.

引用本文的文献

1
The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis.E3 泛素连接酶 HECTD4 调节 COX-2 依赖性肿瘤进展和转移。
Proc Natl Acad Sci U S A. 2025 Aug 12;122(32):e2425621122. doi: 10.1073/pnas.2425621122. Epub 2025 Aug 6.
2
Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis.环氧-氧化脂质与可溶性环氧化物水解酶代谢途径作为非甾体抗炎药诱导的胃肠病和炎症相关致癌作用的靶点
Front Pharmacol. 2019 Jun 25;10:731. doi: 10.3389/fphar.2019.00731. eCollection 2019.
3
Targeting the tumor microenvironment: from understanding pathways to effective clinical trials.
靶向肿瘤微环境：从了解通路到有效的临床试验。
Cancer Res. 2013 Aug 15;73(16):4965-77. doi: 10.1158/0008-5472.CAN-13-0661. Epub 2013 Aug 2.
4
Prostaglandins in cancer cell adhesion, migration, and invasion.前列腺素在癌细胞黏附、迁移和侵袭中的作用
Int J Cell Biol. 2012;2012:723419. doi: 10.1155/2012/723419. Epub 2012 Feb 29.
5
Aspirin and familial adenomatous polyposis: coming full circle.阿司匹林与家族性腺瘤性息肉病：兜兜转转。
Cancer Prev Res (Phila). 2011 May;4(5):623-7. doi: 10.1158/1940-6207.CAPR-11-0157.
6
PharmGKB summary: very important pharmacogene information for PTGS2.PharmGKB总结：关于PTGS2的非常重要的药物基因信息。
Pharmacogenet Genomics. 2011 Sep;21(9):607-13. doi: 10.1097/FPC.0b013e3283415515.
7
Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder.短期塞来昔布治疗浸润性膀胱移行细胞癌的效果。
Mol Cancer Ther. 2010 May;9(5):1371-7. doi: 10.1158/1535-7163.MCT-10-0049. Epub 2010 Apr 27.
8
Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward.环氧化酶-2 与癌症治疗：权衡风险，值得一试。
Clin Cancer Res. 2010 Mar 1;16(5):1384-90. doi: 10.1158/1078-0432.CCR-09-0788. Epub 2010 Feb 23.
9
Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.TP53调节剂CP-31398单独或与低剂量塞来昔布联合使用对雄性F344大鼠中偶氮甲烷诱导的结直肠癌的抑制作用
Cancer Res. 2009 Oct 15;69(20):8175-82. doi: 10.1158/0008-5472.CAN-09-1377. Epub 2009 Oct 13.